GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Additional Paid-In Capital

Notable Labs (Notable Labs) Additional Paid-In Capital : $96.52 Mil(As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Additional Paid-In Capital?


Notable Labs's quarterly additional paid-in capital increased from Dec. 2021 ($2.69 Mil) to Dec. 2022 ($34.06 Mil) and increased from Dec. 2022 ($34.06 Mil) to Dec. 2023 ($96.52 Mil).

Notable Labs's annual additional paid-in capital increased from Dec. 2021 ($2.69 Mil) to Dec. 2022 ($34.06 Mil) and increased from Dec. 2022 ($34.06 Mil) to Dec. 2023 ($96.52 Mil).


Notable Labs Additional Paid-In Capital Historical Data

The historical data trend for Notable Labs's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Additional Paid-In Capital Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Additional Paid-In Capital
2.69 34.06 96.52

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Additional Paid-In Capital 2.69 34.06 96.52

Notable Labs Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Notable Labs Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Notable Labs's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs (Notable Labs) Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.